vs

Side-by-side financial comparison of Aquestive Therapeutics, Inc. (AQST) and Soluna Holdings, Inc (SLNH). Click either name above to swap in a different company.

Aquestive Therapeutics, Inc. is the larger business by last-quarter revenue ($13.0M vs $8.4M, roughly 1.5× Soluna Holdings, Inc). Aquestive Therapeutics, Inc. runs the higher net margin — -244.8% vs -284.7%, a 39.9% gap on every dollar of revenue. On growth, Soluna Holdings, Inc posted the faster year-over-year revenue change (11.8% vs 9.7%). Soluna Holdings, Inc produced more free cash flow last quarter ($-6.8M vs $-8.6M). Over the past eight quarters, Aquestive Therapeutics, Inc.'s revenue compounded faster (3.9% CAGR vs -8.8%).

Aquestive Therapeutics is a specialty pharmaceutical company focused on developing and commercializing innovative treatments for central nervous system disorders. It leverages proprietary drug delivery technologies to create accessible, patient-friendly therapeutic options, serving healthcare providers and patients across North America and European markets, with core offerings addressing unmet needs in neurology and psychiatry.

AQST vs SLNH — Head-to-Head

Bigger by revenue
AQST
AQST
1.5× larger
AQST
$13.0M
$8.4M
SLNH
Growing faster (revenue YoY)
SLNH
SLNH
+2.2% gap
SLNH
11.8%
9.7%
AQST
Higher net margin
AQST
AQST
39.9% more per $
AQST
-244.8%
-284.7%
SLNH
More free cash flow
SLNH
SLNH
$1.7M more FCF
SLNH
$-6.8M
$-8.6M
AQST
Faster 2-yr revenue CAGR
AQST
AQST
Annualised
AQST
3.9%
-8.8%
SLNH

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
AQST
AQST
SLNH
SLNH
Revenue
$13.0M
$8.4M
Net Profit
$-31.9M
$-24.0M
Gross Margin
55.2%
9.5%
Operating Margin
-221.6%
-92.5%
Net Margin
-244.8%
-284.7%
Revenue YoY
9.7%
11.8%
Net Profit YoY
-86.8%
-233.2%
EPS (diluted)
$-0.26
$-1.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AQST
AQST
SLNH
SLNH
Q4 25
$13.0M
Q3 25
$12.8M
$8.4M
Q2 25
$10.0M
$6.2M
Q1 25
$8.7M
$5.9M
Q4 24
$11.9M
$8.3M
Q3 24
$13.5M
$7.5M
Q2 24
$20.1M
$9.7M
Q1 24
$12.1M
$12.5M
Net Profit
AQST
AQST
SLNH
SLNH
Q4 25
$-31.9M
Q3 25
$-15.4M
$-24.0M
Q2 25
$-13.5M
$-7.4M
Q1 25
$-22.9M
$-7.6M
Q4 24
$-17.1M
$-40.0M
Q3 24
$-11.5M
$-7.2M
Q2 24
$-2.7M
$-10.9M
Q1 24
$-12.8M
$-5.3M
Gross Margin
AQST
AQST
SLNH
SLNH
Q4 25
55.2%
Q3 25
64.8%
9.5%
Q2 25
54.4%
6.3%
Q1 25
58.1%
5.7%
Q4 24
61.9%
-360.8%
Q3 24
67.2%
-39.1%
Q2 24
77.5%
34.6%
Q1 24
63.6%
45.4%
Operating Margin
AQST
AQST
SLNH
SLNH
Q4 25
-221.6%
Q3 25
-89.6%
-92.5%
Q2 25
-113.6%
-107.6%
Q1 25
-222.1%
-120.9%
Q4 24
-114.4%
-426.0%
Q3 24
-61.2%
-119.8%
Q2 24
0.3%
-38.0%
Q1 24
-74.3%
3.2%
Net Margin
AQST
AQST
SLNH
SLNH
Q4 25
-244.8%
Q3 25
-120.6%
-284.7%
Q2 25
-135.4%
-119.9%
Q1 25
-263.0%
-127.3%
Q4 24
-143.7%
-483.8%
Q3 24
-85.0%
-95.5%
Q2 24
-13.7%
-112.4%
Q1 24
-106.4%
-41.9%
EPS (diluted)
AQST
AQST
SLNH
SLNH
Q4 25
$-0.26
Q3 25
$-0.14
$-1.14
Q2 25
$-0.14
$-0.93
Q1 25
$-0.24
$-1.21
Q4 24
$-0.18
$-7.14
Q3 24
$-0.13
$-1.56
Q2 24
$-0.03
$-3.62
Q1 24
$-0.17
$-2.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AQST
AQST
SLNH
SLNH
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$27.5M
$13.3M
Stockholders' EquityBook value
$-33.7M
$14.5M
Total Assets
$160.4M
$152.0M
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AQST
AQST
SLNH
SLNH
Q4 25
Q3 25
$129.1M
Q2 25
$60.5M
Q1 25
$68.7M
Q4 24
$71.5M
Q3 24
$77.9M
Q2 24
$89.9M
Q1 24
$95.2M
Total Debt
AQST
AQST
SLNH
SLNH
Q4 25
$27.5M
Q3 25
$45.0M
$13.3M
Q2 25
$45.0M
$10.0M
Q1 25
$45.0M
$10.2M
Q4 24
$32.5M
$7.1M
Q3 24
$45.0M
$8.1M
Q2 24
$45.0M
$9.0M
Q1 24
$45.0M
Stockholders' Equity
AQST
AQST
SLNH
SLNH
Q4 25
$-33.7M
Q3 25
$-4.1M
$14.5M
Q2 25
$-72.6M
$-19.5M
Q1 25
$-60.9M
$-16.1M
Q4 24
$-60.2M
$-12.5M
Q3 24
$-45.4M
$20.9M
Q2 24
$-35.5M
$24.4M
Q1 24
$-36.3M
$21.5M
Total Assets
AQST
AQST
SLNH
SLNH
Q4 25
$160.4M
Q3 25
$163.6M
$152.0M
Q2 25
$93.7M
$92.0M
Q1 25
$102.2M
$90.0M
Q4 24
$101.4M
$88.0M
Q3 24
$110.0M
$97.3M
Q2 24
$117.6M
$98.7M
Q1 24
$129.5M
$90.6M
Debt / Equity
AQST
AQST
SLNH
SLNH
Q4 25
Q3 25
0.92×
Q2 25
Q1 25
Q4 24
Q3 24
0.39×
Q2 24
0.37×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AQST
AQST
SLNH
SLNH
Operating Cash FlowLast quarter
$-8.5M
$-2.2M
Free Cash FlowOCF − Capex
$-8.6M
$-6.8M
FCF MarginFCF / Revenue
-65.7%
-81.4%
Capex IntensityCapex / Revenue
0.7%
55.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-53.0M
$-34.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AQST
AQST
SLNH
SLNH
Q4 25
$-8.5M
Q3 25
$-12.6M
$-2.2M
Q2 25
$-7.9M
$-1.1M
Q1 25
$-23.4M
$-177.0K
Q4 24
$-6.5M
$-5.1M
Q3 24
$-11.9M
$61.0K
Q2 24
$-7.0M
$-7.3M
Q1 24
$-10.4M
$3.9M
Free Cash Flow
AQST
AQST
SLNH
SLNH
Q4 25
$-8.6M
Q3 25
$-12.9M
$-6.8M
Q2 25
$-8.0M
$-9.7M
Q1 25
$-23.5M
$-4.0M
Q4 24
$-6.5M
$-13.9M
Q3 24
$-12.0M
$-3.4M
Q2 24
$-7.0M
$-7.6M
Q1 24
$-10.4M
$3.3M
FCF Margin
AQST
AQST
SLNH
SLNH
Q4 25
-65.7%
Q3 25
-100.6%
-81.4%
Q2 25
-80.2%
-156.8%
Q1 25
-269.9%
-67.1%
Q4 24
-54.8%
-168.3%
Q3 24
-88.3%
-44.8%
Q2 24
-35.0%
-78.2%
Q1 24
-86.4%
26.5%
Capex Intensity
AQST
AQST
SLNH
SLNH
Q4 25
0.7%
Q3 25
1.8%
55.2%
Q2 25
1.1%
139.0%
Q1 25
1.5%
64.2%
Q4 24
0.1%
107.0%
Q3 24
0.6%
45.6%
Q2 24
0.2%
2.5%
Q1 24
0.2%
4.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AQST
AQST

Segment breakdown not available.

SLNH
SLNH

Data Hosting Revenue$5.3M62%
Cryptocurrency Mining Revenue$2.8M33%
Other$389.0K5%

Related Comparisons